TY - CHAP
T1 - Toxicity of Nanomaterials to the Host and the Environment
AU - Beamer, Celine A.
N1 - Publisher Copyright:
© 2020, American Association of Pharmaceutical Scientists.
PY - 2020
Y1 - 2020
N2 - Although silver nanoparticles (AgNPs) display excellent antibacterial, antifungal, and antiviral properties; the pervasiveness of AgNPs in occupational, medicinal, consumer, and environmental settings has raised concerns about the potential for adverse health effects and environmental risks. We provide herein an overview of the use of AgNPs, routes of AgNPS exposure, physicochemical properties and mechanisms responsible for toxicity, and strategies to establish the safety of AgNPs. The core of this book chapter is the notion that while AgNPs may be effective agents in exterminating various pathogens, they may also damage healthy cells, animals, humans, and ecosystems. Thus, the manufacture and usage of AgNPs should be closely monitored and regulated.
AB - Although silver nanoparticles (AgNPs) display excellent antibacterial, antifungal, and antiviral properties; the pervasiveness of AgNPs in occupational, medicinal, consumer, and environmental settings has raised concerns about the potential for adverse health effects and environmental risks. We provide herein an overview of the use of AgNPs, routes of AgNPS exposure, physicochemical properties and mechanisms responsible for toxicity, and strategies to establish the safety of AgNPs. The core of this book chapter is the notion that while AgNPs may be effective agents in exterminating various pathogens, they may also damage healthy cells, animals, humans, and ecosystems. Thus, the manufacture and usage of AgNPs should be closely monitored and regulated.
KW - Dermal exposure
KW - Inhalation exposure
KW - Oral exposure
KW - Properties
KW - Silver nanoparticles
KW - Toxicity
UR - http://www.scopus.com/inward/record.url?scp=85090045698&partnerID=8YFLogxK
U2 - 10.1007/978-3-030-35910-2_10
DO - 10.1007/978-3-030-35910-2_10
M3 - Chapter
AN - SCOPUS:85090045698
T3 - AAPS Advances in the Pharmaceutical Sciences Series
SP - 233
EP - 245
BT - AAPS Advances in the Pharmaceutical Sciences Series
PB - Springer
ER -